Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Diversified Healthcare Trust EV-to-EBITDA?
Diversified Healthcare TrustDHC -0.76%54 EV-to-EBITDA is 51.17 as of Jul. 18, 2026, which is 256% above its 10-year median of 14.39. GuruFocus rates DHC with a GF Score™ of 54/100 and a GF Value™ of $3.20 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 684 REITs companies, Diversified Healthcare Trust ranks worse than 95.61% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Diversified Healthcare Trust's enterprise value is $4,498 Mil.
Diversified Healthcare Trust's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $88 Mil. Therefore, Diversified Healthcare Trust's EV-to-EBITDA for today is 51.17.
The historical rank and industry rank for Diversified Healthcare Trust's EV-to-EBITDA or its related term are showing as below:
DHC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.88 Med: 14.39 Max: 51.93
Current: 51.17
During the past 13 years, the highest EV-to-EBITDA of Diversified Healthcare Trust was 51.93. The lowest was 2.88. And the median was 14.39.
DHC's EV-to-EBITDA is ranked worse than 95.61% of 684
companies
in the REITs industry
Industry Median: 15.52
vs DHC: 51.17
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Diversified Healthcare Trust's PE Ratio (TTM) for today is calculated as:
Diversified Healthcare Trust's share price for today is $9.16.
Diversified Healthcare Trust's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.330.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Healthcare Facilities subindustry, Diversified Healthcare Trust's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diversified Healthcare Trust EV-to-EBITDA vs REITs Industry
For the REITs industry and Real Estate sector, Diversified Healthcare Trust's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Diversified Healthcare Trust's EV-to-EBITDA falls into.
Diversified Healthcare Trust's current Enterprise Value is $4,498 Mil.
Diversified Healthcare Trust's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $88 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diversified Healthcare Trust (DHC) has a EV-to-EBITDA of 51.17 as of Jul. 18, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Diversified Healthcare Trust. This is 256% above median its historical median of 14.39. Over the past decade, Diversified Healthcare Trust's EV-to-EBITDA has ranged from 2.88 to 51.93. According to the industry distribution chart, Diversified Healthcare Trust ranks #654 out of 684 companies in the REITs industry, placing it in the top 95.6%.
Is Diversified Healthcare Trust's EV-to-EBITDA too high?
Diversified Healthcare Trust's current EV-to-EBITDA of 51.17 is 256% above median its 10-year median of 14.39. Over the past 10 years, this metric has ranged from a low of 2.88 to a high of 51.93. The REITs industry median EV-to-EBITDA is 15.52. Diversified Healthcare Trust's value of 51.17 is 229.7% above this industry median. Based on the distribution chart, Diversified Healthcare Trust ranks #654 out of 684 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Diversified Healthcare Trust has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diversified Healthcare Trust's EV-to-EBITDA compare to LTC and MPT?
According to the REITs industry distribution chart, Diversified Healthcare Trust ranks #654 out of 684 companies for EV-to-EBITDA. This places Diversified Healthcare Trust in the lower half of its industry. The industry median EV-to-EBITDA is 15.52. Diversified Healthcare Trust's value of 51.17 is 229.7% above this benchmark. Historically, Diversified Healthcare Trust's own EV-to-EBITDA has ranged from 2.88 to 51.93 over the past decade. While the company's 10-year median is 14.39 vs. the industry median of 15.52, Diversified Healthcare Trust has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a REITs company?
The median EV-to-EBITDA among REITs companies is 15.52, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diversified Healthcare Trust's current EV-to-EBITDA of 51.17 is 229.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Diversified Healthcare Trust. For the REITs industry, the median EV-to-EBITDA is 15.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diversified Healthcare Trust's current EV-to-EBITDA is 51.17, which is 256% above median its own 10-year median of 14.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diversified Healthcare Trust stock overvalued right now?
Based on GuruFocus' analysis, Diversified Healthcare Trust (DHC) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.20, compared to a current price of $9.16 — trading 186.3% above its estimated fair value. The current EV-to-EBITDA is 51.17, which is 256% above median its 10-year median of 14.39 and 229.7% above the REITs industry median of 15.52. Diversified Healthcare Trust's overall GF Score™ is 54/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Diversified Healthcare Trust (DHC), the current EV-to-EBITDA is 51.17 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diversified Healthcare Trust (DHC) Overvalued in 2026?
Based on GuruFocus' analysis, Diversified Healthcare Trust stock appears to be overvalued.
The current stock price of $9.16 is trading 186.3% above its estimated GF Value™ of $3.20.
GuruFocus considers Diversified Healthcare Trust to be Significantly Overvalued.
Key valuation signals for DHC:
EV-to-EBITDA: 51.17 (256% above median its 10-year median of 14.39)
GF Value™: $3.20 vs. price of $9.16 (186.3% above fair value)
Industry Position: 229.7% above the REITs median (#654 of 684)
No single metric tells the full story. See the DHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.
54GF Score
Get the complete analysis for DHC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHC has been successfully added to your 
